Bristol-Myers Squibb: Waste

Bristol-Myers Squibb promotes recycling as a preferred alternative to disposal, but our ultimate goal is to reduce waste generation through source reduction. Our Sustainability 2015 Goal to reduce packaging waste by 5 percent from a 2009 baseline year supports this objective.

From 2010 to 2012, the total amount of nonhazardous waste generated increased by 18.8 percent. From 2010 to 2012, the amount of nonhazardous waste recycled decreased by 27.8 percent absolute.

From 2010 to 2012, the amount of hazardous waste generated increased by 64.5 percent. The amount of hazardous waste recycled increased by 78.9 percent during the same period.

From 2010 to 2012 the total waste generated increased by 33.4 percent, and 46.7 percent when normalized by sales. The increase in waste generated was due to the first full year of full-scale production at our new biologics facility, existing facility capacity expansion and waste generated as a result of Hurricane Sandy.

Bristol-Myers Squibb tracks hazardous waste sent off-site from our facilities worldwide for recycling, reuse, treatment or disposal. Data does not include hazardous waste generated as a result of onsite remediation activities. The vast majority of hazardous waste is incinerated, with only the residual ash disposed to land. Hazardous waste is defined by local, state or country regulations.


You are leaving to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.